Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8144 Walnut Hill Ln
Suite 800
Dallas, TX 75231Phone+1 214-540-0700Fax+1 214-540-0701
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Rheumatology, 1978 - 1980
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1975 - 1978
- University of Alabama School of MedicineClass of 1975
Certifications & Licensure
- TX State Medical License 1978 - 2026
- AL State Medical License 1976 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. Start of enrollment: 2013 Jul 01
- Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis Start of enrollment: 2015 Apr 01
Publications & Presentations
PubMed
- Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.Gerd R Burmester, Laura C Coates, Stanley B Cohen, Yoshiya Tanaka, Ivana Vranic
Rheumatology and Therapy. 2024-02-01 - 4 citationsPost-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.Gerd R Burmester, Laura C Coates, Stanley B Cohen, Yoshiya Tanaka, Ivana Vranic
Rheumatology and Therapy. 2023-10-01 - 2 citationsInfluenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.Kevin L Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal
Rheumatology and Therapy. 2023-04-01
Press Mentions
- RA Awareness Day 2021: Rheumatologists Show Support, Provide Guidance for PatientsFebruary 2nd, 2021
- Newly Identified Cell Type May Help Predict, Treat Rheumatoid Arthritis FlaresJuly 17th, 2020
- ACR Gives Guidance on Rheumatic Disease Management During PandemicMay 12th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: